John S. Grundy
John S. Grundy publishes mostly in Molecular Biology, Immunology and Pediatrics, Perinatology and Child Health, on topics such as Oral and gingival health research, Pharmacogenetics and Drug Metabolism and Drug Transport and Resistance Mechanisms.
- World rank
- #1,753,826 of 7,710,434 ranked researchers
- Rank in United States
- #540,513 of 1,627,098
- Works
- 58
- Citations
- 2k
- Citations per work
- 34.8
What does John S. Grundy research?
John S. Grundy's work is mostly in Biochemistry, Genetics and Molecular Biology (16%), Medicine (15%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3458.1%
- Life Sciences1322.2%
- Health Sciences1119.7%
- Medicine915.4%
- Health Professions24.3%
- 1Molecular Biology16% of their works
- 2Immunology6% of their works
- 3Pediatrics, Perinatology and Child Health6% of their works
- 4Oncology5% of their works
- 5Pharmacy4% of their works
- 6Reproductive Medicine4% of their works
Research topics
- Oral and gingival health research
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Pharmacological Effects and Toxicity Studies
- Sphingolipid Metabolism and Signaling
- Diabetes Treatment and Management
- Pharmaceutical studies and practices
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe John S. Grundy's research?
The keywords of their largest research topics: Drug-Induced, Gingival Overgrowth, Antiepileptic Drugs, ATP-dependent Transporters, Cytochrome P450, Multidrug Resistance, Pharmacogenetics and Prenatal Exposure.
- Therapeutic Antibodies
- Off-Label Drug Use
- Type 2 Diabetes
- Sphingolipids
- Prenatal Exposure
- Multidrug Resistance
- Antiepileptic Drugs
- Gingival Overgrowth
- Drug-Induced
- ATP-dependent Transporters
- Cytochrome P450
- Pharmacogenetics
- Cardiovascular Outcomes
- Sphingosine-1-Phosphate
- Fc Receptors
- Pediatric Pharmacokinetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Drug-Induced71 topic
- Gingival Overgrowth71 topic
- ATP-dependent Transporters61 topic
- Antiepileptic Drugs61 topic
- Cytochrome P45061 topic
- Multidrug Resistance61 topic
- Pharmacogenetics61 topic
- Prenatal Exposure61 topic
- Cardiovascular Outcomes51 topic
- Sphingolipids51 topic
- Sphingosine-1-Phosphate51 topic
- Type 2 Diabetes51 topic
- Fc Receptors41 topic
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Therapeutic Antibodies41 topic
Where does John S. Grundy work?
John S. Grundy's main affiliation in the publication record is Arena Pharmaceuticals (United States), United States.
How many publications and citations does John S. Grundy have?
OpenAlex counts 58 works and 2,021 citations for John S. Grundy, an h-index of 25, ranking #1,753,826 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John S. Grundy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.